MyFinsight
Home
Blog
About
Back
Balance Sheet
Marker Therapeutics, Inc. (MRKR)
Marker Therapeutics, Inc. (MRKR)
source: myfinsight.com
Cash and cash
equivalents
$11,331,023
(8.31%↑ Y/Y)
Other receivables
$1,619,477
(-3.28%↓ Y/Y)
Prepaid expenses and
other current assets
$1,043,676
Restricted cash
$591,309
(-56.30%↓ Y/Y)
Total current assets
$14,585,485
(-1.24%↓ Y/Y)
Total assets
$14,585,485
(-1.24%↓ Y/Y)
Total liabilities and
stockholders' equity
$14,585,485
(-1.24%↓ Y/Y)
Total stockholders'
equity
$12,165,464
(15.97%↑ Y/Y)
Total liabilities
$2,420,021
(-43.42%↓ Y/Y)
Accumulated deficit
-$464,186,305
(-1.91%↓ Y/Y)
Additional paid-in capital
$476,335,097
(2.23%↑ Y/Y)
Total current
liabilities
$2,420,021
(-43.42%↓ Y/Y)
Common stock, 0.001 par
value, 130 million...
$16,672
(47.37%↑ Y/Y)
Accounts payable and
accrued liabilities
$1,023,917
(-54.85%↓ Y/Y)
Related party payable
$804,795
(22.56%↑ Y/Y)
Deferred grant income
$591,309
Back